Nuclear medicine and perspective thoughts in the diagnosis and treatment of pheochromocytoma and paraganglioma
Authors:
- 5 March 2025
- journal article
- review article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 37 (8) , e70017
Abstract
Pheochromocytoma and paraganglioma (PPGL) are rare and life‐threatening tumors of the adrenal medulla and extra‐adrenal paraganglia, respectively. Management of PPGL depends on accurate diagnosis and treatment. This review provides a very comprehensive overview of nuclear medicine in PPGL with some of our perspective views on diagnostic challenges and pitfalls, treatment, and new phase studies. It describes nuclear medicine techniques including 64Cu/68Ga‐DOTA‐SSA, 18F‐FDOPA, 18F‐FDG, 123I‐MIBG, and some emerging molecular imaging agents and PRRT therapies, such as 203Pb VMT‐α‐NET and 212Pb VMT‐α‐NET targeted alpha therapy (TAT). It also provides insight into the use of proliferating cell nuclear antigen (PCNA) inhibitors in combination with therapeutics in aggressive/metastatic PPGL. Through a comprehensive review of the latest developments and clinical practice, this review aims to guide healthcare professionals in improving the diagnostic accuracy and therapeutic efficacy of PPGL.Keywords
This publication has 107 references indexed in Scilit:
- Recent progress in the pathologic classification of pheochromocytomas and paragangliomasBest Practice & Research Clinical Endocrinology & Metabolism, 2024
- Overview of recent guidelines and consensus statements on initial screening and management of phaeochromocytoma and paraganglioma in SDHx pathogenic variant carriers and patientsBest Practice & Research Clinical Endocrinology & Metabolism, 2024
- Pre-clinical phaeochromocytoma and paraganglioma models: Cell lines, animal models, and a human primary culture modelBest Practice & Research Clinical Endocrinology & Metabolism, 2024
- Targeting proliferating cell nuclear antigen (PCNA) for cancer therapy2024
- cGAS-STING at the crossroads in cancer therapyCritical Reviews in Oncology/Hematology, 2023
- Small molecule targeting of transcription-replication conflict for selective chemotherapyCell Chemical Biology, 2023
- Contemporary management of paragangliomas of the head and neckLaryngoscope Investigative Otolaryngology, 2021
- Evading immune surveillance via tyrosine phosphorylation of nuclear PCNACell Reports, 2021
- The impact of infection and inflammation in oncologic 18F-FDG PET/CT imagingBiomedicine & Pharmacotherapy, 2019
- Diagnostic utility of diffusion‐weighted MR imaging and apparent diffusion coefficient value for the diagnosis of adrenal tumorsJournal of Magnetic Resonance Imaging, 2008